For development and supply of an immunosuppressant generic product in USA
Panacea Biotec has entered into a collaboration with a leading international pharmaceutical company for the development and supply of an immunosuppressant generic product in USA. The collaboration has been established on 23 December 2014 for research, development and subsequent ANDA submission for a generic immunosuppressant drug. Under the terms of the agreement, the Company shall receive an upfront Research Fee, as well as a milestone payment linked with the development of the product.Powered by Capital Market - Live News
